The imperative to share clinical study reports: recommendations from the Tamiflu experience.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 22505850.
- Also identified by DOI 10.1371/journal.pmed.1001201 and PMC identifier 3323511.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Peter Doshi and colleagues describe their experience trying and failing to access clinical study reports from the manufacturer of Tamiflu and challenge industry to defend their current position of RCT data secrecy.
Medical subject headings
- Drug Industry
- Information Dissemination
- Oseltamivir
- Outcome Assessment, Health Care
- Randomized Controlled Trials as Topic
- Review Literature as Topic